Ecopharmacovigilance is a crucial aspect of pharmacology that delves into the environmental impact of pharmaceutical substances, specifically focusing on their pharmacodynamics. Pharmacodynamics involves the study of how drugs interact with the body and the subsequent biological responses. In the context of ecopharmacovigilance, it extends beyond human health to assess the effects of pharmaceuticals on ecosystems and wildlife. Understanding the pharmacodynamics of drugs in the environment is vital for evaluating potential ecological risks. It encompasses the examination of how drugs persist, transform, and exert their effects in various environmental compartments. This field explores the intricate interplay between pharmaceuticals and non-target organisms, assessing both short-term and long-term impacts on biodiversity and ecosystem functioning. By scrutinizing pharmacodynamic aspects, ecopharmacovigilance aims to identify potential hazards posed by pharmaceutical residues in the environment and develop strategies to mitigate adverse effects. This involves comprehensive research to comprehend the fate of drugs in environmental matrices, their bioaccumulation, and potential consequences for ecosystems. Ultimately, integrating pharmacodynamics into ecopharmacovigilance practices ensures a holistic approach to pharmaceutical safety, addressing concerns beyond human health to safeguard the delicate balance of our ecosystems.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India